SIA
REVBW icon

Soltis Investment Advisors’s Revelation Biosciences Warrant REVBW Stock Holding History

Soltis Investment Advisors’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318 Hold
47,500
– – ﹤0.01% 580
2025
Q4 		$380 Hold
47,500
– – ﹤0.01% 528
2025
Q3 		$499 Hold
47,500
– – ﹤0.01% 478
2025
Q2 		$570 Buy
+47,500
New +$575 ﹤0.01% 395

Other funds holding REVBW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QWM
Quaker Wealth Management Moorestown, New Jersey $320M AUM 13.7% 1-Year Est. Return

Soltis Investment Advisors's REVBW Position: Q1 2026 in Review

Soltis Investment Advisors held its Revelation Biosciences Warrant (REVBW) position steady in Q1 2026 at 47,500 shares worth $318. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Soltis Investment Advisors first reported a position in REVBW in Q2 2025 and has held it in 4 quarters since. The position peaked at $570 in Q2 2025. 11 funds tracked by Wall St. Rank hold REVBW as of Q1 2026.

  • Soltis Investment Advisors held 47,500 shares of Revelation Biosciences Warrant worth $318 as of Q1 2026.
  • Soltis Investment Advisors left its Revelation Biosciences Warrant share count unchanged in Q1 2026.
  • Revelation Biosciences Warrant made up ﹤0.01% of Soltis Investment Advisors's portfolio in Q1 2026, its #580 holding.
  • Soltis Investment Advisors first reported a position in Revelation Biosciences Warrant in Q2 2025 and has held it in 4 quarters since.
  • Soltis Investment Advisors's Revelation Biosciences Warrant position peaked at $570 in Q2 2025.
  • 11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.